Showing results (581-590 of 768) with videos related to

Sort By:
Pageof 77
International Journal of Cancer|April 13, 2011
Experience with high-risk human papillomavirus testing on vaginal brush-based self-samples of non-attendees of the cervical screening programMurat Gök, Folkert J van Kemenade, Daniëlle A M Heideman, et al.
International Journal of Cancer|November 1, 2011
Human papillomavirus infection in women with and without cervical cancer in Tehran, IranNahid Khodakarami, Gary M Clifford, Parvin Yavari, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 14, 2018
Evaluation of the eighth TNM classification on p16-positive oropharyngeal squamous cell carcinomas in the Netherlands and the importance of additional HPV DNA testingI H Nauta, M M Rietbergen, A A J D van Bokhoven, et al.
ACR Open Rheumatology|August 28, 2025
Data-Driven Cluster Analysis of Cerebrospinal Fluid Proteome and Associations with Clinical Phenotypes in Systemic Lupus ErythematosusElsa Grenmyr, Kristoffer Zervides, Seyed Morteza Najibi, et al.
The Journal of Clinical Endocrinology and Metabolism|February 19, 1998
Two-month treatment of obese subjects with the oral growth hormone (GH) secretagogue MK-677 increases GH secretion, fat-free mass, and energy expenditureJ Svensson, L Lönn, J O Jansson, et al.
Acta Psychiatrica Scandinavica|February 24, 2001
Comparison of key worker and patient assessment of needs in schizophrenic patients living in the community: a Nordic multicentre studyL Hansson, H R Vinding, T Mackeprang, et al.
Rheumatology (Oxford, England)|April 8, 2020
Complement deposition, C4d, on platelets is associated with vascular events in systemic lupus erythematosusElisabet Svenungsson, Johanna T Gustafsson, Giorgia Grosso, et al.
BMC Rheumatology|January 26, 2025
Altered medial temporal lobe subregion volumes in systemic lupus erythematosus patients with neuropsychiatric symptomsZ Makdad Najeeb, P C Sundgren, A Jönsen, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|July 14, 1998
Treatment with the oral growth hormone secretagogue MK-677 increases markers of bone formation and bone resorption in obese young malesJ Svensson, C Ohlsson, J O Jansson, et al.
Pageof 77